COMMUNIQUÉS West-GlobeNewswire

[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for dual GLP-1/GIP receptor agonist enicepatide in people living with type 2 diabetes and overweight or obesity
22/09/2026
At the highest dose (24 mg), enicepatide achieved a mean HbA1c reduction of 2.65% at 48 weeks, highlighting its potential for best-in-disease glycemic control In patients with poor baseline glycemic control (HbA1c >8 [...]
Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026
22/09/2026
Leniolisib was generally well-tolerated, with clinical improvements across multiple measures of immune dysregulation, including reductions in lymphoproliferation Separately, Pharming expects to report topline results [...]
DXS INTERNATIONAL PLC (AQSE: DXSP) ANNUAL RESULTS FY 30 APRIL 2026
22/09/2026
The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union ( [...]
HighLife lève plus de 90 millions de dollars pour lancer son étude pivot aux États-Unis et accélérer son développement commercial en Europe
22/09/2026
Paris, France - le 22 septembre 2026 – HighLife SAS, Medtech spécialisée dans les solutions transcathéter destinées au traitement des maladies cardiaques structurelles, annonce aujourd’hui avoir réalisé avec succès une [...]
HighLife Raises $90+ Million to start its US Pivotal Study and accelerate Commercial Expansion in Europe
22/09/2026
Paris, France, September 22 – HighLife SAS, a MedTech company focused on transcatheter solutions for structural heart disease, today announced the successful completion of a $90+ Million (€80 Million) financing round . [...]
Opterion Health Announces Positive Phase 1 Results for OPT101, Supporting Advancement to Phase 2a
22/09/2026
SPARC study achieved all its objectives, establishing a strong clinical foundation for a differentiated, non-glucose-based treatment for peritoneal dialysis Positive Phase 1 results strengthen confidence in OPT101 , [...]
Dialybrid secures €15 million series A round and announces successful first-in-human implant of novel Silkothane® Arteriovenous Graft for vascular access in hemodialysis
22/09/2026
Silkothane® Arteriovenous Graft is a novel hybrid arteriovenous graft engineered to integrate into patients’ vessels and provide a safe, easy-to-cannulate, durable, vascular access for hemodialysis in patients with end- [...]
AstronauTx awarded research funding from The Michael J. Fox Foundation and Parkinson’s UK to explore sleep-based approaches for Parkinson's disease
22/09/2026
MJFF grant will support development of a potential disease-modifying treatment for prodromal Parkinson's disease by targeting restorative sleep mechanisms Parkinson's UK-funded research with University College London ( [...]
His Choice Health Opens Richmond Vasectomy Clinic, Bringing Single-Visit Care to Virginia
22/09/2026
New Richmond location expands access to minimally invasive no-scalpel vasectomy with transparent pricing, single-visit scheduling and mail-in follow-up testing. Richmond, VA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- His [...]
Respiree Extends Series A Syndicate with Addition of International Investors to Support Continued Global Growth
22/09/2026
HOUSTON and SINGAPORE, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Respiree , a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced [...]
LA Limited Addition Drumline, Breast Cancer Prevention Advocates Join Actress Dionne Lea and Renowned Breast Cancer Surgeon Dr. Kristi Funk to Rally in View Park to “Beat” Breast Cancer
21/09/2026
LOS ANGELES, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Breast cancer prevention advocates, nutrition experts, and community members will gather for a special Let’s Beat Breast Cancer rally from 1 to 3 p.m. on Sunday, Sept. 27 [...]
Le KFSH figure dans le classement 2027 des meilleurs hôpitaux spécialisés au monde établi par Newsweek
21/09/2026
RIYAD, Arabie saoudite, 21 sept. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH) consolide sa position parmi les établissements de santé de référence à l’échelle mondiale en [...]
TestoPrime 2026: Announces Updated TestoPrime Gold Supplement Natural Testosterone Booster For Men for Men’s Over 40.
21/09/2026
TestoPrime announces updated TestoPrime Gold and ingredients information, offering insights into a natural testosterone booster Supplement for men over 40 and men’s wellness. New York, Sept. 21, 2026 (GLOBE NEWSWIRE [...]
Nyxoah Annonce une Transition au Poste de Chief Financial Officer
21/09/2026
INFORMATIONS RÉGLEMENTÉES INFORMATIONS PRIVILÉGIÉES Nyxoah Annonce une Transition au Poste de Chief Financial Officer Loïc Moreau, President International et ancien CFO de Nyxoah, assurera l’intérim au poste de CFO La [...]
Nyxoah Announces Chief Financial Officer Transition
21/09/2026
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Chief Financial Officer Transition Loïc Moreau, Nyxoah’s President International and former CFO, to serve as interim CFO Company reaffirms full year 2026 [...]
Vireo Growth Inc. Completes Acquisition of M3 Wellness, a Nevada Dispensary
21/09/2026
MINNEAPOLIS, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced the closing of its previously announced indirect acquisition of M3 Wellness, a [...]
Xenon to Present at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
21/09/2026
VANCOUVER, BC and BOSTON, MA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and [...]
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
21/09/2026
RADNOR, Pa., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026
21/09/2026
Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026 Chris Rabbat succédera à Fabio Cataldi au poste de Directeur médical (« Chief Medical Officer » ou « CMO ») ; [...]

Pages